Trade

with

Accuray Inc
(NASDAQ: ARAY)
AdChoices
7.03
-0.10
-1.40%
After Hours :
-
-
-

Open

7.16

Previous Close

7.13

Volume (Avg)

231.49k (748.14k)

Day's Range

6.98-7.17

52Wk Range

6.46-10.85

Market Cap.

551.15M

Dividend Rate ( Yield )

-

Beta

0.85

Shares Outstanding

77.36M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Devices
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 369.42M

    • Net Income

    • -35.45M

    • Market Cap.

    • 551.15M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -9.60

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.85

    • Forward P/E

    • -30.96

    • Price/Sales

    • 1.46

    • Price/Book Value

    • 5.59

    • Price/Cash flow

    • 1,666.67

      • EBITDA

      • 2.42M

      • Return on Capital %

      • -7.30

      • Return on Equity %

      • -34.52

      • Return on Assets %

      • -7.30

      • Book Value/Share

      • 1.27

      • Shares Outstanding

      • 77.36M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 12.13

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • -0.24

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 20.10

          • 2.66

          • Net Income

            YTD/YTD (last year)

          • -

          • -22.64

          • Net Income

            Q/Q (last year)

          • -

          • -29.83

          • Sales (Revenue)

            5-Year Annual Average

          • 9.60

          • 4.60

          • Net Income

            5-Year Annual Average

          • -

          • -1.34

          • Dividends

            5-Year Annual Average

          • -

          • -0.25

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 38.66

            • 64.08

            • Pre-Tax Margin

            • -8.76

            • 15.19

            • Net Profit Margin

            • -9.60

            • 13.09

            • Average Gross Margin

              5-Year Annual Average

            • 39.70

            • 65.03

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -13.50

            • 17.99

            • Average Net Profit Margin

              5-Year Annual Average

            • -14.10

            • 191.75B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 1.98

              • 0.34

              • Current Ratio

              • 1.97

              • 2.55

              • Quick Ratio

              • 1.32

              • 1.83

              • Interest Coverage

              • -

              • 11.70

              • Leverage Ratio

              • 5.02

              • 1.86

              • Book Value/Share

              • 1.27

              • 11.69

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -15.58

                • 34.48

                • P/E Ratio 5-Year High

                • -23.74

                • 224.03

                • P/E Ratio 5-Year Low

                • -7.45

                • 60.23

                • Price/Sales Ratio

                • 1.50

                • 3.20

                • Price/Book Value

                • 5.74

                • 3.23

                • Price/Cash Flow Ratio

                • 1,666.67

                • 18.66

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -34.52

                    (-29.60)

                  • 12.33

                    (18.16)

                  • Return on Assets %

                    (5-Year Average)

                  • -7.30

                    (-10.20)

                  • 6.62

                    (8.69)

                  • Return on Capital %

                    (5-Year Average)

                  • -11.82

                    (-15.50)

                  • 8.49

                    (11.48)

                  • Income/Employee

                  • -

                  • 34.11k

                  • Inventory Turnover

                  • 2.68

                  • 2.77

                  • Asset Turnover

                  • 0.76

                  • 0.51

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -18.14M
                  Operating Margin
                  -4.91
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  1,666.67
                  Ownership

                  Institutional Ownership

                  -

                  Top 10 Institutions

                  53.51%

                  Mutual Fund Ownership

                  51.05%

                  Float

                  74.26%

                  5% / Insider Ownership

                  4.28%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • PrimeCap Odyssey Aggressive Growth Fund

                  •  

                    3,666,900

                  • -0.53

                  • 4.75

                  • PrimeCap Odyssey Growth Fund

                  •  

                    3,623,600

                  • 0.00

                  • 4.70

                  • Fidelity® OTC Portfolio

                  •  

                    2,427,800

                  • 0.00

                  • 3.14

                  • Buffalo Small Cap Fund

                  •  

                    2,127,600

                  • 0.00

                  • 2.76

                  • Heartland Value Fund

                  •  

                    1,500,000

                  • 0.00

                  • 1.94

                  • Buffalo Discovery

                  •  

                    1,428,400

                  • -1.41

                  • 1.85

                  • Vanguard US Opportunities

                  •  

                    1,400,200

                  • -3.31

                  • 1.81

                  • Vanguard Small Cap Index

                  •  

                    1,269,297

                  • -0.12

                  • 1.64

                  • Vanguard Total Stock Mkt Idx

                  •  

                    1,170,907

                  • 0.00

                  • 1.51

                  • iShares Russell 2000 (AU)

                  •  

                    1,166,530

                  • -1.81

                  • 1.48

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • PRIMECAP Management Company

                  •  

                    8,690,700

                  • -1.08%

                  • 11.26

                  • Fidelity Management and Research Company

                  •  

                    6,787,228

                  • -38.32%

                  • 8.78

                  • Kornitzer Capital Management Inc

                  •  

                    5,029,725

                  • -2.83%

                  • 6.52

                  • Vanguard Group, Inc.

                  •  

                    4,532,762

                  • -0.24%

                  • 5.87

                  • Oracle Investment Management Inc

                  •  

                    3,616,293

                  • +11.61%

                  • 4.69

                  • Robeco Investment Management, Inc.

                  •  

                    2,432,860

                  • -4.36%

                  • 3.15

                  • LAPIDES ASSET MANAGEMENT, LLC

                  •  

                    2,339,600

                  • 0.00%

                  • 3.03

                  • BlackRock Fund Advisors

                  •  

                    2,132,366

                  • -8.01%

                  • 2.76

                  • Redmile Group, LLC

                  •  

                    1,866,260

                  • +26.50%

                  • 2.42

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Devices

                  Type

                  Speculative Growth

                  Style

                  Small Value

                  Accuray Inc was incorporated in California in 1990 and commenced operations in 1992. The Company was reincorporated in 2007 in Delaware. The Company is a radiation oncology company. The Company’s technologies are designed specificall...morey to deliver precise radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, and image guided radiation therapy and adaptive radiation therapy tailored to the specific needs of each patient. Its suite of products includes the CyberKnife® Systems and the TomoTherapy® Systems. The CyberKnife Systems are fully robotic stereotactic radiosurgery systems, or SRS and stereotactic body radiation therapy systems, or SBRT used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and c...moreorrect for tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimeter accuracy while patients breathe normally. Treatment with the CyberKnife Systems requires no anesthesia, and can be performed in one to five staged treatment sessions on an outpatient basis. In addition, the CyberKnife Systems are designed to minimize many of the risks and complications that are associated with other treatment options. The CyberKnife Systems include: the CyberKnife G4, which includes the Fixed collimator; CyberKnife® VSI™ System, which includes the Fixed and Iris collimators and the new CyberKnife M6 Series System, that comes in configurations that have the option of Fixed collimator, Iris collimator, and a MultiLeaf collimator, or MLC. The TomoTherapy Systems are used to treat a wide range of cancers and tumors, and enable efficient daily imaging to ensure the accuracy of the patient position before each treatment delivery. The TomoTherapy Systems operate on ring gantries and combine integrated CT imaging with intensity modulated radiation therapy or IMRT, which is designed to deliver radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. The TomoTherapy Systems include the Hi-Art® System, delivering CT-guided, helical IMRT; the TomoHD™ System, which includes both the TomoHelicalTM and TomoDirectTM treatment modalities and the Tomo H TM Series Systems that come in configuration options of TomoHTM, TomoHD™ and TomoHDATM and which includes one or more options such as TomoHelicalTM, TomoDirectTM, High Performance VoLo TM Planning and TomoEdge Dynamic Jaws.lessless

                  Key People

                  Mr. Joshua H. Levine

                  CEO/Director/President

                  Mr. Louis J. Lavigne, Jr

                  Chairman of the Board/Director

                  Ms. Elizabeth H. Davila

                  Director/Vice Chairman of the Board

                  Gregory E. Lichtwardt

                  CFO/Chief Accounting Officer/Executive VP, Divisional

                  Ms. Kelly Londy

                  Executive VP/Other Executive Officer

                  • Accuray Inc

                  • 1310 Chesapeake Terrace

                  • Sunnyvale, CA 94089

                  • USA.Map

                  • Phone: +1 408 716-4600

                  • Fax: +1 408 716-4601

                  • accuray.com

                  Incorporated

                  1990

                  Employees

                  1,026

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: